Carl Van Laer

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study

D. Schrijvers, C. van Herpen, Joseph Kerger et al. · Annals of Oncology · 2004 · 87 citations · Full text

Medicine, Oncology, Chemotherapy +8

Phase I trial of a cisplatin‐albumin complex for the treatment of cancer of the head and neck.

J. D. Holding, W E Lindup, Carl Van Laer et al. · British Journal of Clinical Pharmacology · 1992 · 50 citations · Full text

Medicine, Oncology, Pharmacology +15

Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response

Carolien Boeckx, Christine Weyn, Isabelle Vanden Bempt et al. · BMC Research Notes · 2014 · 40 citations · Full text

Medicine, Molecular Biology, Oncology +17

Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)

Margot Baudelet, Leen Van den Steen, Fréderic Duprez et al. · Trials · 2020 · 32 citations · Full text

Medicine, Oncology, Speech-language Pathology +16

The Potential of Helical Tomotherapy in the Treatment of Head and Neck Cancer

Dirk Van Gestel, Dirk Verellen, Lien Van De Voorde et al. · The Oncologist · 2013 · 30 citations

Medicine, Oncology, Radiation Oncology +15